Study summary

The purpose of this study is to evaluate the safety and pharmacokinetics of enfortumab vedotin as well as assess the immunogenicity and antitumor activity in subjects with metastatic urothelial cancer and other malignant solid tumors that express Nectin-4.

Additional Study Details

Phase
Phase 1
Product
  • enfortumab vedotin
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    213
    Show Additional Study Details

    Study documents

    Clinical Study Report
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site CA00001
      Edmonton, AB, Canada, T6G 1Z2
      Completed
      Site US00008
      Tampa, FL, United States, 33612
      Completed
      Site US00017
      Aurora, CO, United States, 80045
      Withdrawn
      Site US00001
      Seattle, WA, United States, 98109
      Completed
      Site CA00010
      Toronto, ON, Canada, M5G 2M9
      Completed
      Site US00020
      Pittsburgh, PA, United States, 15232
      Completed
      Site US00005
      Ann Arbor, MI, United States, 48109
      Completed
      Site US00007
      Miami, FL, United States, 33136
      Completed
      Site US00009
      Madison, WI, United States, 53792
      Completed
      Site US00019
      Stanford, CA, United States, 94305
      Completed
      Site CA00011
      Calgary, AB, Canada, T2N 4N2
      Withdrawn
      Site US00014
      Baltimore, MD, United States, 21201
      Completed
      Site US00021
      Las Vegas, NV, United States, 89119
      Withdrawn
      Site US00025
      Spokane, WA, United States, 99208
      Completed
      Site US00004
      Fairway, KS, United States, 66205
      Completed
      Site US00024
      Fairfax, VA, United States, 22031
      Withdrawn
      Site US00026
      Omaha, NE, United States, 68130
      Completed
      Site US00013
      Philadelphia, PA, United States, 19111
      Completed
      Site US00006
      New Haven, CT, United States, 06520
      Completed
      Site US00002
      New York, NY, United States, 10065
      Withdrawn
      Site US00022
      Dallas, TX, United States, 75251
      Completed
      Site US00003
      Detroit, MI, United States, 48201
      Completed
      Site US00023
      Chapel Hill, NC, United States, 27599
      Completed
      Site US00018
      New York, NY, United States, 10029
      Withdrawn
      Site US00027
      Harvey, IL, United States, 60426
      Completed
      Site US00015
      Milwaukee, WI, United States, 53226
      Withdrawn
      Site US00016
      Indianapolis, IN, United States, 46202
      Completed
      Site US00012
      Los Angeles, CA, United States, 90033

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?